IL2 and acute myeloid leukemia: HLA-B −21M/T dimorphism is associated with susceptibility to HIV [44], the killing of HIV-infected cells by NK cells [45], NK cell anti-leukemic activity, and the overall survival of acute myeloid leukemia patients under IL-2 immunotherapy [46].